Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MC2-25 cream in vulvar lichen sclerosus
NCT06132919Phase 2Completed
- Sponsor
- MC2 Therapeutics
- Start
- Oct 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MC2-25 cream in vulvar lichen sclerosus (LS), sponsored by MC2 Therapeutics. Started Oct 2023; status: completed.
02
Drugs
MC2-25 cream
03
Conditions
vulvar lichen sclerosus (LS)
Beyond the preview
Go deeper on NCT06132919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06132919.